BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 30455597)

  • 1. Stakeholder involvement in Multi-Criteria Decision Analysis.
    Thokala P; Madhavan G
    Cost Eff Resour Alloc; 2018; 16(Suppl 1):0. PubMed ID: 30455597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developing a Multi-Criteria Decision Analysis Tool to Support the Adoption of Evidence-Based Child Maltreatment Prevention Programs.
    Cruden G; Frerichs L; Powell BJ; Lanier P; Brown CH; Lich KH
    Prev Sci; 2020 Nov; 21(8):1059-1064. PubMed ID: 33040271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Balancing costs and benefits at different stages of medical innovation: a systematic review of Multi-criteria decision analysis (MCDA).
    Wahlster P; Goetghebeur M; Kriza C; Niederländer C; Kolominsky-Rabas P;
    BMC Health Serv Res; 2015 Jul; 15():262. PubMed ID: 26152122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can multi-criteria decision analysis (MCDA) be implemented into real-world drug decision-making processes? A Canadian provincial experience.
    Laba TL; Jiwani B; Crossland R; Mitton C
    Int J Technol Assess Health Care; 2020 Aug; ():1-6. PubMed ID: 32762789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Use of MCDA in HTA: Great Potential, but More Effort Needed.
    Marsh KD; Sculpher M; Caro JJ; Tervonen T
    Value Health; 2018 Apr; 21(4):394-397. PubMed ID: 29680094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple stakeholders in multi-criteria decision-making in the context of Municipal Solid Waste Management: A review.
    Soltani A; Hewage K; Reza B; Sadiq R
    Waste Manag; 2015 Jan; 35():318-28. PubMed ID: 25301545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using an innovative criteria weighting tool for stakeholders involvement to rank MSW facility sites with the AHP.
    De Feo G; De Gisi S
    Waste Manag; 2010 Nov; 30(11):2370-82. PubMed ID: 20444589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amplifying Each Patient's Voice: A Systematic Review of Multi-criteria Decision Analyses Involving Patients.
    Marsh K; Caro JJ; Hamed A; Zaiser E
    Appl Health Econ Health Policy; 2017 Apr; 15(2):155-162. PubMed ID: 27928659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient involvement in reflective multicriteria decision analysis to assist decision making in oncology.
    Badia X; Aguarón A; Fernández A; Gimón A; Nafria B; Gaspar B; Guarga L; Gálvez M; Fuentes M; Paco N; Saldaña R
    Int J Technol Assess Health Care; 2019 Jan; 35(1):56-63. PubMed ID: 30730288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-Criteria Decision Analysis for Assessment and Appraisal of Orphan Drugs.
    Iskrov G; Miteva-Katrandzhieva T; Stefanov R
    Front Public Health; 2016; 4():214. PubMed ID: 27747207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stakeholder engagement in dredged material management decisions.
    Collier ZA; Bates ME; Wood MD; Linkov I
    Sci Total Environ; 2014 Oct; 496():248-256. PubMed ID: 25089686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knowledge Translation in Practice: Exploring the Potential Use of MCDA in Central America and the Caribbean.
    Espinoza MA; Rojas R; Acosta de Patiño H
    Value Health Reg Issues; 2018 Dec; 17():148-149. PubMed ID: 30184512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How to support the application of multiple criteria decision analysis? Let us start with a comprehensive taxonomy.
    Cinelli M; Kadziński M; Gonzalez M; Słowiński R
    Omega; 2020; 96():. PubMed ID: 33746337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-Criteria Decision Analysis (MCDA) for sustainability assessment in food sector. A systematic literature review on methods, indicators and tools.
    Ferla G; Mura B; Falasco S; Caputo P; Matarazzo A
    Sci Total Environ; 2024 Jun; 946():174235. PubMed ID: 38944301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Applying a Multicriteria Decision Analysis (MCDA) Approach to Elicit Stakeholders' Preferences in Italy: The Case of Obinutuzumab for Rituximab-Refractory Indolent Non-Hodgkin Lymphoma (iNHL).
    Garau M; Hampson G; Devlin N; Mazzanti NA; Profico A
    Pharmacoecon Open; 2018 Jun; 2(2):153-163. PubMed ID: 29623625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bridging health technology assessment (HTA) and efficient health care decision making with multicriteria decision analysis (MCDA): applying the EVIDEM framework to medicines appraisal.
    Goetghebeur MM; Wagner M; Khoury H; Levitt RJ; Erickson LJ; Rindress D
    Med Decis Making; 2012; 32(2):376-88. PubMed ID: 21987539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MCDA Index Tool: an interactive software to develop indices and rankings.
    Cinelli M; Spada M; Kim W; Zhang Y; Burgherr P
    Environ Syst Decis; 2021; 41(1):82-109. PubMed ID: 32837823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Setting health sector priorities: a brief overview of Ethiopia's experience.
    Habtemariam MK; Semegn ST
    Cost Eff Resour Alloc; 2018; 16(Suppl 1):46. PubMed ID: 30455605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of multi-criteria decision analysis (MCDA) framework for off-patent pharmaceuticals - an application on improving tender decision making in Indonesia.
    Inotai A; Brixner D; Maniadakis N; Dwiprahasto I; Kristin E; Prabowo A; Yasmina A; Priohutomo S; Németh B; Wijaya K; Kalo Z
    BMC Health Serv Res; 2018 Dec; 18(1):1003. PubMed ID: 30594250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utilization of multiple-criteria decision analysis (MCDA) to support healthcare decision-making FIFARMA, 2016.
    Drake JI; de Hart JCT; Monleón C; Toro W; Valentim J
    J Mark Access Health Policy; 2017; 5(1):1360545. PubMed ID: 29081919
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.